|5 packs: Save||3%||= € 91,18 per pack|
|10 packs: Save||5%||= € 89,30 per pack|
|20 packs: Save||8%||= € 86,48 per pack|
|30 packs: Save||10%||= € 84,60 per pack|
CINGAL® is a unique combination of cross-linked hyaluronic acid and triamcinolone hexacetonide designed to safely and effectively treat the pain and certain symptoms associated with osteoarthritis. Hyaluronic acid (HA) is a natural substance produced by the body. The chemical is normally found in high amounts in the joint tissue and in the fluid that encircles the joints. In cases of osteoarthritis, the amount of natural HA is reduced and the quality may be poorer than normal, which causes irritation and inflammation, pain and stiffness in the joints. CINGAL® adds HA to the joints where it acts as a lubricant and shock absorber, while the triamcinolone hexacetonide reduces the inflammation. CINGAL® only requires a single injection to achieve fast acting and long lasting pain relief.
The pack consists of:
- 1 Syringe x 4ml per pack
The composition of CINGAL®:
- 88 mg Hyaluronic acid
- 18 mg Triamcinolone hexacetonide
Benefits of CINGAL®:
- Immediate pain relief and better joint mobility
- Long lasting results
- Areas: Approved for all synovial joints
How long does the result last for?
In general, CINGAL® can relieve knee pain up to 6 months. Some patients experience pain relief for longer than 6 months.
THE ORIGIN OF THIS PRODUCT IS FROM THE EUROPEAN COMMUNITY (EC)
Anika Therapeutics is a global medical tech company that offers wound healing, pain management and tissue regeneration. They develop innovative medical solutions in order to help patients remain active in a safe and natural way. Anika Therapeutics is a manufactory that distributes a wide range of hyaluronic acid (HA) products specialized in therapeutic applications. HA is a natural component of the body that is vital to healthy tissue function. The brand only collaborates with industry leaders that deliver the newest therapeutic and advanced healthcare.